Molecular markers distinguish bone marrow mesenchymal stem cells from fibroblasts - PubMed (original) (raw)

. 2005 Jun 24;332(1):297-303.

doi: 10.1016/j.bbrc.2005.04.118.

Chika Koike, Akira Igarashi, Katsuyuki Yamanaka, Haiou Pan, Yukihito Higashi, Hiroyuki Kawaguchi, Masaru Sugiyama, Nobuyuki Kamata, Tomoyuki Iwata, Takehiro Matsubara, Kozo Nakamura, Hidemi Kurihara, Koichiro Tsuji, Yukio Kato

Affiliations

Molecular markers distinguish bone marrow mesenchymal stem cells from fibroblasts

Masakazu Ishii et al. Biochem Biophys Res Commun. 2005.

Abstract

To characterize mesenchymal stem cells (MSC), we compared gene expression profiles in human bone marrow MSC (11 lines) and human fibroblasts (4 lines) by RT-PCR and real time PCR. Messenger RNA levels of MHC-DR-alpha, MHC-DR-beta, MHC-DR-associated protein CD74, tissue factor pathway inhibitor-2, and neuroserpin were much higher in MSC than in fibroblasts, even in the presence of large interindividual variations. Those of adrenomedullin, apolipoprotein D, C-type lectin superfamily member-2, collagen type XV alpha1, CUG triplet repeat RNA-binding protein, matrix metalloproteinase-1, protein tyrosine kinase-7, and Sam68-like phosphotyrosine protein/T-STAR were lower in MSC than in fibroblasts. FACS analysis showed that cell surface expression of MHC-DR was also higher in MSC than in fibroblasts. MHC-DR expression decreased after osteogenic differentiation, whereas the expression of adrenomedullin-a potent stimulator of osteoblast activity-along with collagen XV alpha1 and apolipoprotein D increased after osteogenic differentiation. The marker genes identified in this study should be useful for characterization of MSC both in basic and clinical studies.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources